Lavipharm S.A. is a Greek pharmaceutical company founded in 1911, specializing in the research, development, and manufacturing of pharmaceutical, dermocosmetic, and healthcare products. They offer prescription medicines, OTC products, and transdermal drug delivery systems (TDDS) for cardiology, oncology, CNS, and chronic pain. Their target audience includes healthcare professionals and consumers globally. The unique selling proposition is their expertise in TDDS and innovative healthcare solutions, positioning them as a partner of choice for international pharmaceutical companies. Lavipharm aims to improve quality of life through reliable and innovative treatment options[1][3][5].